Wyeth Investors Likely To Win Class Cert. In Pristiq Case

Law360, New York (May 10, 2012, 9:35 PM EDT) -- A New York federal judge on Thursday said he will likely grant class certification to a group of investors who claim Pfizer Inc. unit Wyeth Pharmaceuticals Inc. did not disclose serious side effects associated with the antidepressant Pristiq.

Investors led by a pipe fitters union have asked to go forward as a class in a suit claiming Wyeth, then an independent company, committed securities fraud by failing to disclose heart- and liver-related side effects that appeared during Pristiq's clinical trials.

“I'm going to reserve [judgment] but...
To view the full article, register now.

Related

Sections

Case Information

Case Title

City of Livonia Employees' Retirement System v. Essner et al


Case Number

1:07-cv-10329

Court

New York Southern

Nature of Suit

Securities/Commodities

Judge

Richard J. Sullivan

Date Filed

November 13, 2007

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.